CD90-Targeted Viral Particles enable in vivo HSC genetic engineering.

The study looks at human HSC antigen targets and applications of novel viral particles to genetically modify human hematopoietic stem cells.本研究聚焦于人类造血干细胞（Hematopoietic Stem Cells, HSC）的抗原靶点，以及新型病毒颗粒在人类造血干细胞基因修饰中的应用。